Weight Loss and Slowing Growth Rate in Pediatric Patients with ADHD In a controlled trial of VYVANSE in pediatric patients ages 6 to 12 years (Study 1), mean weight loss from baseline after 4 weeks of therapy was -0.9, -1.9, and -2.5 pounds, respectively, for patients receiving 30 mg, 50 mg, and 70 mg of VYVANSE, compared to a 1 pound weight gain for patients receiving placebo
Paraxanthine provides greater improvement in cognitive function than caffeine after performing a 10-km run
Medical disclaimer: Lab testing supports informed decisions but does not diagnose every medication complication or replace professional medical care
Open Heart 2015
* Helps transport fatty acids into the mitochondria , where they are used as fuel for energy Supports fat metabolism , contributing to weight management Promotes the production of cellular energy , enhancing physical performance & endurance Supports the function of the heart and muscles , improving cellular oxygenation Reduces levels of cholesterol and triglycerides in the blood while improving the ratio between HDL and LDL cholesterol
How does retatrutide differ mechanistically from semaglutide
